Blocking Peptides Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: BF42B06E6158EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Blocking Peptides in global, including the following market information:

Global Blocking Peptides Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Blocking Peptides Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Blocking Peptides companies in 2020 (%)

The global Blocking Peptides market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blocking Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blocking Peptides Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Blocking Peptides Market Segment Percentages, By Type, 2020 (%)

• SSX2 Blocking Peptide
• KLK2 Blocking Peptide
• FZD4 Blocking Peptide
• SPDEF Blocking Peptide
• Others

Global Blocking Peptides Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Blocking Peptides Market Segment Percentages, By Application, 2020 (%)

• Immunity Therapy
• Chemical Analysis
• Others

Global Blocking Peptides Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Blocking Peptides Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Blocking Peptides revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Blocking Peptides revenues share in global market, 2020 (%)

Key companies Blocking Peptides sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Blocking Peptides sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• amsbio
• Abcam
• Fitzgerald Industries International
• Aviva Systems Biology
• Alomone Labs
• Merck
• Abcepta

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Blocking Peptides Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Blocking Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BLOCKING PEPTIDES OVERALL MARKET SIZE

2.1 Global Blocking Peptides Market Size: 2021 VS 2027
2.2 Global Blocking Peptides Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Blocking Peptides Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Blocking Peptides Players in Global Market
3.2 Top Global Blocking Peptides Companies Ranked by Revenue
3.3 Global Blocking Peptides Revenue by Companies
3.4 Global Blocking Peptides Sales by Companies
3.5 Global Blocking Peptides Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Blocking Peptides Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Blocking Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blocking Peptides Players in Global Market
  3.8.1 List of Global Tier 1 Blocking Peptides Companies
  3.8.2 List of Global Tier 2 and Tier 3 Blocking Peptides Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Blocking Peptides Market Size Markets, 2021 & 2027
  4.1.2 SSX2 Blocking Peptide
  4.1.3 KLK2 Blocking Peptide
  4.1.4 FZD4 Blocking Peptide
  4.1.5 SPDEF Blocking Peptide
  4.1.6 Others
4.2 By Type - Global Blocking Peptides Revenue & Forecasts
  4.2.1 By Type - Global Blocking Peptides Revenue, 2016-2021
  4.2.2 By Type - Global Blocking Peptides Revenue, 2022-2027
  4.2.3 By Type - Global Blocking Peptides Revenue Market Share, 2016-2027
4.3 By Type - Global Blocking Peptides Sales & Forecasts
  4.3.1 By Type - Global Blocking Peptides Sales, 2016-2021
  4.3.2 By Type - Global Blocking Peptides Sales, 2022-2027
  4.3.3 By Type - Global Blocking Peptides Sales Market Share, 2016-2027
4.4 By Type - Global Blocking Peptides Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Blocking Peptides Market Size, 2021 & 2027
  5.1.2 Immunity Therapy
  5.1.3 Chemical Analysis
  5.1.4 Others
5.2 By Application - Global Blocking Peptides Revenue & Forecasts
  5.2.1 By Application - Global Blocking Peptides Revenue, 2016-2021
  5.2.2 By Application - Global Blocking Peptides Revenue, 2022-2027
  5.2.3 By Application - Global Blocking Peptides Revenue Market Share, 2016-2027
5.3 By Application - Global Blocking Peptides Sales & Forecasts
  5.3.1 By Application - Global Blocking Peptides Sales, 2016-2021
  5.3.2 By Application - Global Blocking Peptides Sales, 2022-2027
  5.3.3 By Application - Global Blocking Peptides Sales Market Share, 2016-2027
5.4 By Application - Global Blocking Peptides Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Blocking Peptides Market Size, 2021 & 2027
6.2 By Region - Global Blocking Peptides Revenue & Forecasts
  6.2.1 By Region - Global Blocking Peptides Revenue, 2016-2021
  6.2.2 By Region - Global Blocking Peptides Revenue, 2022-2027
  6.2.3 By Region - Global Blocking Peptides Revenue Market Share, 2016-2027
6.3 By Region - Global Blocking Peptides Sales & Forecasts
  6.3.1 By Region - Global Blocking Peptides Sales, 2016-2021
  6.3.2 By Region - Global Blocking Peptides Sales, 2022-2027
  6.3.3 By Region - Global Blocking Peptides Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Blocking Peptides Revenue, 2016-2027
  6.4.2 By Country - North America Blocking Peptides Sales, 2016-2027
  6.4.3 US Blocking Peptides Market Size, 2016-2027
  6.4.4 Canada Blocking Peptides Market Size, 2016-2027
  6.4.5 Mexico Blocking Peptides Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Blocking Peptides Revenue, 2016-2027
  6.5.2 By Country - Europe Blocking Peptides Sales, 2016-2027
  6.5.3 Germany Blocking Peptides Market Size, 2016-2027
  6.5.4 France Blocking Peptides Market Size, 2016-2027
  6.5.5 U.K. Blocking Peptides Market Size, 2016-2027
  6.5.6 Italy Blocking Peptides Market Size, 2016-2027
  6.5.7 Russia Blocking Peptides Market Size, 2016-2027
  6.5.8 Nordic Countries Blocking Peptides Market Size, 2016-2027
  6.5.9 Benelux Blocking Peptides Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Blocking Peptides Revenue, 2016-2027
  6.6.2 By Region - Asia Blocking Peptides Sales, 2016-2027
  6.6.3 China Blocking Peptides Market Size, 2016-2027
  6.6.4 Japan Blocking Peptides Market Size, 2016-2027
  6.6.5 South Korea Blocking Peptides Market Size, 2016-2027
  6.6.6 Southeast Asia Blocking Peptides Market Size, 2016-2027
  6.6.7 India Blocking Peptides Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Blocking Peptides Revenue, 2016-2027
  6.7.2 By Country - South America Blocking Peptides Sales, 2016-2027
  6.7.3 Brazil Blocking Peptides Market Size, 2016-2027
  6.7.4 Argentina Blocking Peptides Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Blocking Peptides Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Blocking Peptides Sales, 2016-2027
  6.8.3 Turkey Blocking Peptides Market Size, 2016-2027
  6.8.4 Israel Blocking Peptides Market Size, 2016-2027
  6.8.5 Saudi Arabia Blocking Peptides Market Size, 2016-2027
  6.8.6 UAE Blocking Peptides Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 amsbio
  7.1.1 amsbio Corporate Summary
  7.1.2 amsbio Business Overview
  7.1.3 amsbio Blocking Peptides Major Product Offerings
  7.1.4 amsbio Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.1.5 amsbio Key News
7.2 Abcam
  7.2.1 Abcam Corporate Summary
  7.2.2 Abcam Business Overview
  7.2.3 Abcam Blocking Peptides Major Product Offerings
  7.2.4 Abcam Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.2.5 Abcam Key News
7.3 Fitzgerald Industries International
  7.3.1 Fitzgerald Industries International Corporate Summary
  7.3.2 Fitzgerald Industries International Business Overview
  7.3.3 Fitzgerald Industries International Blocking Peptides Major Product Offerings
  7.3.4 Fitzgerald Industries International Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.3.5 Fitzgerald Industries International Key News
7.4 Aviva Systems Biology
  7.4.1 Aviva Systems Biology Corporate Summary
  7.4.2 Aviva Systems Biology Business Overview
  7.4.3 Aviva Systems Biology Blocking Peptides Major Product Offerings
  7.4.4 Aviva Systems Biology Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.4.5 Aviva Systems Biology Key News
7.5 Alomone Labs
  7.5.1 Alomone Labs Corporate Summary
  7.5.2 Alomone Labs Business Overview
  7.5.3 Alomone Labs Blocking Peptides Major Product Offerings
  7.5.4 Alomone Labs Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.5.5 Alomone Labs Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Blocking Peptides Major Product Offerings
  7.6.4 Merck Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.6.5 Merck Key News
7.7 Abcepta
  7.7.1 Abcepta Corporate Summary
  7.7.2 Abcepta Business Overview
  7.7.3 Abcepta Blocking Peptides Major Product Offerings
  7.4.4 Abcepta Blocking Peptides Sales and Revenue in Global (2016-2021)
  7.7.5 Abcepta Key News

8 GLOBAL BLOCKING PEPTIDES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Blocking Peptides Production Capacity, 2016-2027
8.2 Blocking Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Blocking Peptides Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BLOCKING PEPTIDES SUPPLY CHAIN ANALYSIS

10.1 Blocking Peptides Industry Value Chain
10.2 Blocking Peptides Upstream Market
10.3 Blocking Peptides Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Blocking Peptides Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Blocking Peptides in Global Market
Table 2. Top Blocking Peptides Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Blocking Peptides Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Blocking Peptides Revenue Share by Companies, 2016-2021
Table 5. Global Blocking Peptides Sales by Companies, (K Units), 2016-2021
Table 6. Global Blocking Peptides Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Blocking Peptides Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Blocking Peptides Product Type
Table 9. List of Global Tier 1 Blocking Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blocking Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Blocking Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Blocking Peptides Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Blocking Peptides Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Blocking Peptides Sales (K Units), 2016-2021
Table 15. By Type - Global Blocking Peptides Sales (K Units), 2022-2027
Table 16. By Application – Global Blocking Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Blocking Peptides Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Blocking Peptides Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Blocking Peptides Sales (K Units), 2016-2021
Table 20. By Application - Global Blocking Peptides Sales (K Units), 2022-2027
Table 21. By Region – Global Blocking Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Blocking Peptides Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Blocking Peptides Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Blocking Peptides Sales (K Units), 2016-2021
Table 25. By Region - Global Blocking Peptides Sales (K Units), 2022-2027
Table 26. By Country - North America Blocking Peptides Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Blocking Peptides Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Blocking Peptides Sales, (K Units), 2016-2021
Table 29. By Country - North America Blocking Peptides Sales, (K Units), 2022-2027
Table 30. By Country - Europe Blocking Peptides Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Blocking Peptides Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Blocking Peptides Sales, (K Units), 2016-2021
Table 33. By Country - Europe Blocking Peptides Sales, (K Units), 2022-2027
Table 34. By Region - Asia Blocking Peptides Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Blocking Peptides Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Blocking Peptides Sales, (K Units), 2016-2021
Table 37. By Region - Asia Blocking Peptides Sales, (K Units), 2022-2027
Table 38. By Country - South America Blocking Peptides Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Blocking Peptides Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Blocking Peptides Sales, (K Units), 2016-2021
Table 41. By Country - South America Blocking Peptides Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Blocking Peptides Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Blocking Peptides Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Blocking Peptides Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Blocking Peptides Sales, (K Units), 2022-2027
Table 46. amsbio Corporate Summary
Table 47. amsbio Blocking Peptides Product Offerings
Table 48. amsbio Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Abcam Corporate Summary
Table 50. Abcam Blocking Peptides Product Offerings
Table 51. Abcam Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Fitzgerald Industries International Corporate Summary
Table 53. Fitzgerald Industries International Blocking Peptides Product Offerings
Table 54. Fitzgerald Industries International Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Aviva Systems Biology Corporate Summary
Table 56. Aviva Systems Biology Blocking Peptides Product Offerings
Table 57. Aviva Systems Biology Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Alomone Labs Corporate Summary
Table 59. Alomone Labs Blocking Peptides Product Offerings
Table 60. Alomone Labs Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Merck Corporate Summary
Table 62. Merck Blocking Peptides Product Offerings
Table 63. Merck Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Abcepta Corporate Summary
Table 65. Abcepta Blocking Peptides Product Offerings
Table 66. Abcepta Blocking Peptides Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Blocking Peptides Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 68. Global Blocking Peptides Capacity Market Share of Key Manufacturers, 2019-2021
Table 69. Global Blocking Peptides Production by Region, 2016-2021 (K Units)
Table 70. Global Blocking Peptides Production by Region, 2022-2027 (K Units)
Table 71. Blocking Peptides Market Opportunities & Trends in Global Market
Table 72. Blocking Peptides Market Drivers in Global Market
Table 73. Blocking Peptides Market Restraints in Global Market
Table 74. Blocking Peptides Raw Materials
Table 75. Blocking Peptides Raw Materials Suppliers in Global Market
Table 76. Typical Blocking Peptides Downstream
Table 77. Blocking Peptides Downstream Clients in Global Market
Table 78. Blocking Peptides Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Blocking Peptides Segment by Type
Figure 2. Blocking Peptides Segment by Application
Figure 3. Global Blocking Peptides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Blocking Peptides Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Blocking Peptides Revenue, 2016-2027 (US$, Mn)
Figure 7. Blocking Peptides Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blocking Peptides Revenue in 2020
Figure 9. By Type - Global Blocking Peptides Sales Market Share, 2016-2027
Figure 10. By Type - Global Blocking Peptides Revenue Market Share, 2016-2027
Figure 11. By Type - Global Blocking Peptides Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Blocking Peptides Sales Market Share, 2016-2027
Figure 13. By Application - Global Blocking Peptides Revenue Market Share, 2016-2027
Figure 14. By Application - Global Blocking Peptides Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Blocking Peptides Sales Market Share, 2016-2027
Figure 16. By Region - Global Blocking Peptides Revenue Market Share, 2016-2027
Figure 17. By Country - North America Blocking Peptides Revenue Market Share, 2016-2027
Figure 18. By Country - North America Blocking Peptides Sales Market Share, 2016-2027
Figure 19. US Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Blocking Peptides Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Blocking Peptides Sales Market Share, 2016-2027
Figure 24. Germany Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 25. France Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Blocking Peptides Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Blocking Peptides Sales Market Share, 2016-2027
Figure 33. China Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 37. India Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Blocking Peptides Revenue Market Share, 2016-2027
Figure 39. By Country - South America Blocking Peptides Sales Market Share, 2016-2027
Figure 40. Brazil Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Blocking Peptides Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Blocking Peptides Sales Market Share, 2016-2027
Figure 44. Turkey Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Blocking Peptides Revenue, (US$, Mn), 2016-2027
Figure 48. Global Blocking Peptides Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Blocking Peptides by Region, 2020 VS 2027
Figure 50. Blocking Peptides Industry Value Chain
Figure 51. Marketing Channels